Lipodystrophy body-shape changes in a patient undergoing zidovudine monotherapy.
García-Benayas
Teresa
T
Blanco
Francisco
F
Gómez-Viera
Jose Manuel
JM
Barrios
Ana
A
Soriano
Vincent
V
González-Lahoz
Juan
J
D000273:Adipose Tissue / Q000473:pathology; D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016207:Cytokines / Q000378:metabolism; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D007333:Insulin Resistance; D008060:Lipodystrophy / Q000139:chemically induced* / Q000473:pathology; D009765:Obesity / Q000150:complications / Q000473:pathology; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D015215:Zidovudine / Q000009:adverse effects* / Q000627:therapeutic use
D019380:Anti-HIV Agents; D016207:Cytokines; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine